2025 has been a milestone year at Headlands Research, marked by continued growth, new opportunities for sponsors, and strategic partnerships that position our network for the future. Now, our team is looking forward to connecting with peers and partners at upcoming conferences through the year-end.
Expanding Our Network and Capabilities
The first half of the year marked several important achievements for Headlands Research that expand our reach and strengthen our mission to improve lives by advancing innovative medical therapies:
Launch of the Association of Multisite Research Corporations (AMRC)
In January, Headlands Research became a founding member of the AMRC, a new trade association formed by 14 leading multisite clinical research corporations (MCRCs). With a global footprint of more than 370 sites and nearly 900 PIs, AMRC highlights the unique strengths of MCRCs, such as scalability, centralized operations, data consistency, and robust support for investigators. Through this collaboration, Headlands is helping to shape best practices and demonstrate the efficiencies that MCRCs bring to sponsors, CROs, regulators, and ultimately, participants.
Acquisition of CMRCenter (San Juan, Puerto Rico)
In July, we welcomed CMRCenter (CMRC) into the Headlands network, bringing our site total to 22 across the U.S., Canada, and the Caribbean. This acquisition offers sponsors turnkey access to one of the largest Hispanic participant populations under FDA oversight, accelerating enrollment in vaccine, CNS, and specialty studies.
Opening of Headlands Research Twin Cities (Minneapolis–St. Paul, MN)
In August, we opened our 23rd fully owned site, strategically located in the Upper Midwest. Headlands Research Twin Cities provides pharmaceutical sponsors and CROs with single-contract access to diverse participant populations in a region known for innovation and excellence in healthcare.
THL Partners Acquisition of Headlands Research
Also in August, we announced a definitive agreement for Headlands Research to be acquired by THL Partners, a premier private equity firm. This partnership will fuel our continued expansion, strengthen our centralized infrastructure, and enhance our ability to deliver high-quality, diverse clinical trial data for sponsors worldwide.
Where to Meet Us Next
The momentum doesn’t stop there. Headlands Research team members will be participating in several upcoming industry conferences, continuing important conversations around advancing clinical research:
DPHARM 2025: September 16th – 17th
Connect with McKenzie Lang, Director of Business Development, to learn how Headlands approaches recruitment, operations, and project management to keep studies on track.
SCRS Global Site Solutions Summit: September 28th – October 1st
Meet our team to learn how a participant-first approach and proven best practice strategies help us achieve large-volume recruitment and retention while delivering the highest quality data.
Don’t miss our team on stage:
- Neurology & Alzheimer’s Roundtable – Monday, Sept. 29 (2 PM, Collier/Columbia). Dr. Linda Pao, Principal Investigator at JEM Research Institute, will be a featured participant in this conversation on advancing neurology and Alzheimer’s research.
- Panel Discussion: "Business Development: Comprehensive KPI Blueprint for Sites" – Tuesday, Sept. 30 (1:30–2:30 PM, Flagler/Gilchrist). Our Chief Business Development Officer, Lauren Chazal, will join other leaders to explore which KPIs truly move the needle in clinical research and how sites can best showcase their strengths.
CNS Summit: November 2nd – 5th
Chat with Tori Wallenberg, Director of Business Development, Headlands Research, about the Headlands Research site network's decades of CNS experience and our track record of recruiting, enrolling, and retaining inclusive, diverse populations.
ObesityWeek: November 4th – 7th
Connect with Ryan Cady, Director of Endocrine/Metabolic/Pain Strategy, McKenzie Lang, Director of Business Development, Christopher Romero, Medical Director for Headlands Research and Principal Investigator (PI) at Headlands Research Brownsville, Lawrence Sher, Medical Director at PRA, or Jason Agran, Principal Investigator at CRA, at ObesityWeek 2025. Ask about our Endocrine/Metabolic Program offers coordinated support from across our site network, including:
- Strategic protocol reviews
- PI study feedback and engagement
- Network study solutioning
- Operational planning and coordination
CTAD (Clinical Trials on Alzheimer’s Disease): December 1st – 4th
Learn how our expert recruitment strategies, diverse participant access through site databases and physician partnerships, and commitment to Alzheimer’s disease research support the success of our sponsor and CRO partners at CTAD. Schedule a time to chat with:
- Jordan Wertheimer, Director of Business Development
- Lauren Chazal, Chief Business Development Officer
- Belinda Russell, Director of Recruitment Strategy
- Eric Chavez, Associate Medical Director at Artemis Institute
- Linda Pao, Principal Investigator at JEM Research Institute
- Mark Goldstein, Medical Director at JEM Research Institute
Scottsdale Headache Symposium: December 4th – 7th
Our team is closing out the year at the 2025 Scottsdale Headache Symposium! Connect with us to chat about how trials across our network are informing migraine care and expanding treatment options.
Driving the Future of Clinical Research
As we head into the second half of 2025, Headlands Research remains focused on building a best-in-class network of clinical trial sites, strengthening sponsor partnerships, and ensuring access and inclusion in research for diverse participant populations. We’re excited for the road ahead and look forward to connecting with many of you at these events!